J&J falls after medical devices sales miss Wall Street estimates

Shares of drug and medical device maker Johnson & Johnson JNJ.N fall 1% to $152.75

JNJ reports medical device sales of $8.02 billion for the quarter, which came in below analysts' estimates of $8.17 billion, as per LSEG data

Sales of J&J's medical devices have missed Wall Street estimates for the past 4 quarters

Co also flagged a $400 million impact from tariffs, mostly related to tariffs already in place for China and Mexico that could hurt its medical device business

"We would caution that JNJ has some of the highest China exposure (~10%) in MedTech," said JP Morgan analysts

Overall, JNJ reported Q1 profit and revenue above analysts' expectations

As of last close, JNJ stock up 6.7% YTD